PROPRANOLOL
APHP210075
Phase 3 small_molecule active
Quick answer
PROPRANOLOL for Von Hippel-Lindau (VHL) disease is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Von Hippel-Lindau (VHL) disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active